EN1 influencer platform IconicReach sees rapid Q1 growth
engage:BDR (ASX:EN1) has provided an encouraging update on the progress of its rapidly growing IconicReach Instagram influencer marketing business, along with an overview of the IconicReach business in general.
IconicReach was launched by EN1 at the Sundance Film Festival in early 2018. Since then it has received considerable interest from a range of influencers, and in mid-April had 800+ influencers registered. New influencer registrations are being received at a current approximate rate of 100 per month and the company expects this to continue.
Due to the rapid uptake of the platform, EN1 has increased its original projected revenue from $1.2 million to $3 million for the 2018 financial year; further, it is expected that the IconicReach business will be profitable and cash flow positive within its first full year of operation.
The company has added 66 advertising customers on the IconicReach platform, from industries such as health and beauty, clothing, electronics accessories, cryptocurrency, online lottery and medical marijuana companies.
Within the first three months of 2018, the IconicReach team has already achieved the original total annual budget. The revenue projection has accordingly been increased to $3 million for CY2018 and it is likely that the $3 million revised forecast will also be exceeded.
Further, the margins being achieved in EN1’s IconicReach business are nearly 140% of that being achieved in its core, programmatic advertising business.
EN1 Chief Executive Officer, Ted Dhanik said: “The $3 million revised forecast should be exceeded for the year as we have seen unprecedented demand from companies keen to engage with their target markets through the influencers we have signed.
“IconicReach has a range of features that make it a unique product in the market. It is one of the world’s first self-serve Instagram marketing platforms. The IconicReach platform lets brands browse and discover influencers, create campaigns, and reach customers through limited time advertisements posted by those influencers.
“IconicReach provides unique capabilities for Instagram influencer marketing through such activities as discovering influencers for a specific marketing campaign, providing engagement data to better vet influencers, measuring advertisers’ return on investment (ROI), providing comprehensive reporting and data analytics systems and allowing brands to launch campaigns across hundreds of pages with one click”.
Yet EN1 does remain a speculative investment and investors should take a cautious approach to any investment decision made with regard to this stock.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.